Treatment of non-small-cell lung cancer: a perspective on the recent advances and the experience with gefitinib

Worldwide, non-small-cell lung cancer (NSCLC) is a leading cause of cancer-related mortality and, until screening detects early disease, treatment for the majority of patients will consist of radiation therapy, chemotherapy or combinations thereof. Modern mono and doublet chemotherapy regimens have...

Descripción completa

Detalles Bibliográficos
Autores principales: Onn, A, Tsuboi, M, Thatcher, N
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2004
Materias:
Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2750809/
https://www.ncbi.nlm.nih.gov/pubmed/15340373
http://dx.doi.org/10.1038/sj.bjc.6602062

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2750809/
https://www.ncbi.nlm.nih.gov/pubmed/15340373
http://dx.doi.org/10.1038/sj.bjc.6602062

Ejemplares similares